Abigail L. Jenkins
Board Member
Aquestive Therapeutics, Inc. (AQST)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Abigail L. Jenkins
Abigail L. Jenkins is recorded as Board Member at Aquestive Therapeutics, Inc. (AQST). Aquestive Therapeutics, Inc. reported in an 8-K filed April 1, 2024 that Abigail L. Jenkins was appointed Class II director, effective April 1, 2024.
“On April 1,2024, Aquestive Therapeutics, Inc. (the "Company") announced the appointment of Abigail L. Jenkins to the Board of Directors of the Company (the "Board"), effective April 1, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Aquestive Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Daniel Barber CEO, Board Member
- Gregory B. Brown Chairman
- John S. Cochran Chairman
- A. Ernest Toth CFO
- A. Ernest Toth, Jr. CFO
- Cassie Jung COO
- Thomas A. Zalewski General Counsel
- Julie Krop Board Member
- Marco Taglietti Board Member
- Richard J. Daly Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.